Ignite Creation Date:
2024-05-06 @ 10:34 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03294694
Status:
TERMINATED
Last Update Posted:
2022-03-31
First Post:
2017-09-19
Brief Title:
Ribociclib PDR001 in Breast Cancer and Ovarian Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-19
First Submit QC Date:
September 25 2017
Study First Post Date:
2017-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-16
Last Update Post Date:
2022-03-31
Last Update Post Date Type:
ACTUAL